Burning Rock Biotech (FRA:6BU0) Short Interest


FRA:6BU0 Burning Rock Biotech Ltd FRA:6BU0
55 GF Score
Price €6.00
GF Value €5.43
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Burning Rock Biotech Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:6BU0 vs FONR, XGN, QUCY: Short Interest Comparison

For the Diagnostics & Research subindustry, Burning Rock Biotech's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Burning Rock Biotech Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Burning Rock Biotech's Short Interest distribution charts can be found below:

* The bar in red indicates where Burning Rock Biotech's Short Interest falls into.


FRA:6BU0
55GF Score
Burning Rock Biotech Ltd FRA:6BU0
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Burning Rock Biotech (FRA:6BU0) Overvalued in 2026?

Based on GuruFocus' analysis, Burning Rock Biotech stock appears to be overvalued. The current stock price of €6.00 is trading 10.5% above its estimated GF Value™ of €5.43. GuruFocus considers Burning Rock Biotech to be Modestly Undervalued.

Key valuation signals for FRA:6BU0:

  • Short Interest:
  • GF Value™: €5.43 vs. price of €6.00 (10.5% above fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the FRA:6BU0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Burning Rock Biotech Business Description

Other Exchanges BNR:USA
Address No. 5, Xingdao Ring Road North, International Bio Island, Guangzhou, CHN, 510005
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
55GF Score

Get the complete analysis for FRA:6BU0

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.00
Price
€5.43
GF Value